Radiopharm Theranostics RADX Cash Flow Statement (2023-2026)

NASDAQ RADX
$1.44 -0.18 (-11.11%)
As of: Oct 1, 2026 · 10:36 AM EDT
Reported Financials

Radiopharm Theranostics Quarterly Cash Flow Statement

Periods 4 quarters
Latest Jun 2026

Radiopharm Theranostics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 4 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2023 Jun2024 Jun2025 Jun2026
Operating Activities
Net Income -34.61M-47.95M-38.34M-40.40M
Share-based CompensationStock Comp. -3.04M-2.64M-1.90M-1.71M

Radiopharm Theranostics Cash Flow Statement API

Pull Radiopharm Theranostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RADX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY